Molecular basis for selective eosinophil trafficking in asthma: A multistep paradigm

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 5, 1999, Pages 917-926

  Wardlaw, Andrew L ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Adhesion; Asthma; Chemotaxis; Eosinophils; Migration

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGENICITY; ASTHMA; CYTOKINE RELEASE; EOSINOPHILIA; HUMAN; LEUKOCYTE MIGRATION; NEUTROPHIL CHEMOTAXIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0032760049     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70069-2     Document Type: Article

References (103)

1. 1. Wardlaw A J, Moqbel R, Kay AB. Eosinophils: biology and role in disease. Adv Immunol 1995;60:151-264.
2. 2. Kay AB, Stechschulte DJ, Austen KF. An eosinophil leukocyte chemotactic factor of anaphylaxis. J Exp Med 1971;133:602-19.
3. 3. Sehmi R, Cromwell O, Taylor GW. Identification of guinea pig eosinophil chemotactic factor of anaphylaxis as leukotriene B4 and 8(S), 15(S)-dihydroxy-5,9,11,13 (Z,E Z,E)-eicosatetranoic acid. J Immunol 1991;147:2276-83.
4. 4. Goetzl EJ, Austen KF. Purification and synthesis of eosinophilotactic tetrapeptides of human lung: identification as eosinophil chemotactic factor of anaphylaxis. Proc Natl Acad Sci U S A 1975;72:4123-7.
5. 5. Wardlaw AJ, Moqbel R, Cromwell O, Kay AB. Platelet activating factor is a potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 1986;78:1701-6.
6. 6. Bradding P. Human mast cell cytokines. Clin Exp Allergy 1996;26:13-9.
7. 7. Sanderson CJ. Interleukin-5, eosinophils and disease. Blood 1992;79:3101-9.
8. 8. Bochner BS, Schleimer RP. The role of adhesion molecules in human eosinophil and basophil recruitment. J Allergy Clin Immunol 1994;94:427-38.
9. 9. Rothenburg ME. Eosinophilia. N Engl J Med 1998;338:1592-600.
10. 10. Weller PF. The immunobiology of eosinophilis. N Engl J Med 1991;324:1110-8.
11. 11. Kay AB. Pathology of mild, severe and fatal asthma. Am J Crit Care Med 1996;154:566-9.
12. 12. Denburg JA. The origins of basophils and eosinophils in allergic inflammation. J Allergy Clin Immunol 1998;102(Suppl):S74-6.
13. 13. Hamid Q, Azzawi M, Sun Ying, Moqbel R, Wardlaw AJ. Expression of mRNA for interleukin 5 in mucosal bronchial biopsies from asthma. J Clin invest 1991;87:1541-6.
14. 14. Lee JJ, McGarry MI, Farmer SC, Denzler KL, Larson KA, Carrigan PE, et al. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 1997;185:2143-56.
15. 15. Minshall EM, Schleimer R, Cameron L, Minnicozzi M, Egan RW, Gutierrez-Ramos JC, et al. Interleukin-5 expression in the bone marrow of sensitized Balb/c mice after allergen challenge. Am J Respir Crit Care Med 1998;158:951-7.
16. 16. Robinson DS, Damia R, Zeibecoglou K, Molet S, North J, Yamada T, et al. CD34+/interleukin-5 R alpha messenger RNA+ cells in the bronchial mucosa in asthma: potential airway eosinophil progenitors. Am J Respir Cell Mol Biol 1999;20:9-13.
17. 17. Garlisi CG, Kung TT, Wang P, Minnicozzi M, Umland SP, Chapman RW, et al. Effects of chronic anti-interleukin-5 monoclonal antibody treatment in a murine model of pulmonary inflammation. Am J Respir Cell Mol Biol 1999;20:248-55.
18. 18. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airway hyperreactivity and lung damage in a mouse asthma model. J Exp Med 1996;183:195-210.
19. 19. Sehmi R, Wardlaw AJ, Cromwell O, Kurihara K, Waltmann P, Kay AB. Interleukin 5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood 1992;79:2952-9.
20. 20. Mould AW, Matthaei KI, Young IG, Foster PS. Relationship between intefieukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J Clin Invest 1997;99:1064-71.
21. 21. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ. Cooperation between interleukin 5 and the chemokine cotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995;182:1169-74.
22. 22. Wang J, Palmer K, Lotvall J, Milan S, Lei XF, Matthaei KI, et al. Circulating but not local lung IL-5 is required for the development of antigen-induced airways eosinophilia. J Clin Invest 1998;102:1132-41.
23. 23. Palframan RT, Collins PD, Williams TJ, Rankin SM. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 1998;91:2240-8.
24. 24. Palframan RT, Collins PD, Severs NJ, Rothery S, Williams TJ, Rankin SM. Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: the role of specific adhesion molecules and phosphotidylinositol 3-kinase. J Exp Med 1998;188:1621-32.
25. 25. Wardlaw AJ. Adhesion molecules. In: Barnes P, Roger I, Thompson N, editors. Asthma: basic mechanisms and clinical management. London: Academic Press; 1998. p 239-51.
26. 26. Grayson MH, Van der Vieren M, Sterbinsky SA, Gallatin MW, Hoffman PA, Staunton DE, et al. Alpha d beta 2 integrin is expressed on human eosinophils and functions as an alternative ligand for vascular cell adhesion molecule I (VCAM-1). J Exp Med 1998;188:2187-91.
27. 27. Yamamoto H, Sedgwick JB, Busse WW. Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells. J Immunol 1998;161:971-7.
28. 28. Blease K, Seybold J, Adcock IM, Hellewell PG, Burke-Gaffney A. Interleukin-4 and lipopolysaccharide synergize to induce vascular cell adhesion molecule-1 expression in human lung micro-vascular endothelial cells. Am J Respir Cell Mol Biol 1998;18:620-30.
29. 29. Fukuda T, Fukushima Y, Numao T, Ando N, Arima M, Nakajima H, et al. Role of interleukin-4 and vascular cell adhesion molecule-1 in selective eosinophil migration into the airways in allergic asthma. Am J Respir Cell Mol Biol 1996;14:84-94.
30. 30. Beck LA, Stellato C, Beall LD, Schall TJ, Leopold D, Bickel CA, et al. Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps. J Allergy Clin Immunol 1996;98:766-80.
31. 31. Matsumoto K, Sterbinsky SA, Bickel CA, Zhou DF, Kovach NL, Bochner BS. Regulation of alpha 4 integrin-mediated adhesion of human eosinophils to fibronectin and vascular cell adhesion molecule-1. J Allergy Clin Imunol 1997;99:648-56.
32. 32. Sriramarao P, Von-Adrian UH, Butcher EC, Bourdon MA, Broide DH. L-selectin and very late antigen-4 integrin promote eosinophil rolling at physiological shear stress rates in vivo. J Immunol 1994;152:4238-46.
33. 33. Kitayama J, Fuhlbrigge RC, Puri KD, Springer TA. P-selectin, L-selectin and a4 integrin have distinct roles in eosinophil tethering and arrest on vascular endothelial cells under physiological flow conditions. J Immunol 1997;159:3929-39.
34. 34. Ulfman LH, Kuijper PH, van der Linden JA, Lammers JW, Zwaginga JJ, Koenderman L. Characterisation of eosinophil adhesion to TNF-alpha activated endothelium under flow conditions: alpha 4 integrins mediate initial attachment and E-selectin mediates rolling. J Immunol 1999;163:343-50.
35. 35. Richards IM, Kolbasa KP, Hatfield CA, Winterrowd GE, Vonderfed SL, Fidler S, et al. Role of VLA-4 in the antigen induced accumulation of eosinophils and lymphocytes in the lungs and airway of sensitized brown Norway rats. Am J Respir Cell Mol Biol 1996;15:172-83.
36. 36. Henderson WR, Chi EY, Albert RK, Chu SJ, Lamm WJ, Rochen Y, et al. Blockade of CD49d (alpha 4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. J Clin Invest 1997;100:13083-92.
37. 37. Symon FA, Lawrence MB, Walsh GM, Watson SR, Wardlaw AJ. Characterisation of the eosinophil P-selectin ligand. J Immunol 1996;157:1711-9.
38. 38. Khew-Goodall Y, Wadham C, Stein BN, Gamble JR, Vadas MA. Stat 6 activation is essential for interleukin-4 induction of P-selectin transcription in human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol 1999;19:1421-9.
39. 39. Yao L, Pan J, Setiadi H, Patel KD, McEver RP. Inverleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells. J Exp Med 1996;184:81-92.
40. 40. Woltmann G, McNulty CA, Dewson G, Symon FA, Wardlaw AJ. PSGL-1 mediates the adhesion of eosinophils, but not neutrophils, to IL-13 stimulted HUVEC under flow. Am J Respir Crit Care Med 1989;159:A20.
41. 41. Patel KD. Eosinophil tethering to interleukin-4 activated endothelial cells requires both P-selectin and vascular cell adhesion molecule-1. Blood 1998,92:3904-11.
42. 42. Symon FA, Walsh GM, Watson S, Wardlaw AJ. Eosinophil adhesion to nasal polyp endothelium is P-selectin dependent. J Exp Med 1994;180:371-6.
43. 43. Hamilos DL, Thawley SE, Kramper MA, Kamil A, Hamid QA. Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflammatory cytokine mRNA in nasal polyp disease. J Allergy Clin Imunol 1999;103:79-87.
44. 44. Broide DH, Humber D, Sullivan S, Sriramarao P. Inhibition of eosinophil rolling and recruitment in P-selectin and intercellular adhesion molecule I deficient mice. Blood 1998;91:2847-56.
45. 45. Broide DH, Sullivan S, Gifford T, Sriramarao P. Inhibition of pulmonary eosinophilia in P-selectin and ICAM-1 deficient mice. Am J Respir Cell Mol Biol 1998;18:218-25.
46. 46. De Sanctis GT, Wolyniec WW, Green FHY Qun S, Jiao S, Finn PW, et al. Reduction of allergic airway responses in P-selectin deficient mice. J Appl Physiol 1997;83:681-7.
47. 47. Henriques GM, Miotla OJM, Cordeiro RSB, Wolitzky BA, Woolley ST, Hellewell PG. Selectins mediate eosinophil recruitment in vivo: a comparison with their role in neutrophil influx. Blood 1996;87:5297-301.
48. 48. Sriramarao P, Norton CR, Borgstrom P, DiScipio RG, Wolitsky BA, Broide DH. E-selectin preferentially supports neutrophil but not eosinophil rolling under conditions of flow in vitro and in vivo. J Immunol 1996;157:4672-80.
49. 49. Teixeira MM, Hellewell PG. Contribution of endothelial selectins and alpha-4 integrins to eosinophil trafficking in allergic and non-allergic inflammatory reactions in skin. J Immunol 1998;161:2516-23.
50. 50. Yang J, Furie BC, Furie B. The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leucocyte-endothelial leukocyte-platelet interaction. Thromb Haemost 1999;81:1-7.
51. 51. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996;272:60-6.
52. 52. Zimmerman GA, McIntyre TM, Prescott SM. Adhesion and signalling in vascular cell-cell interactions. J Clin Invest 1997;100:S3-5.
53. 53. Burke-Gaffney A, Hellewell PG. Eotaxin stimulates eosinophil adhesion to human lung microvascular endothelial cells. Biochem Biophys Res Commun 1996;227:35-40.
54. 54. Weber C, Kitayama J, Springer TA. Differential regulation of beta 1 and beta 2 integrin avidity by chemoattractants in eosinophils. Proc Natl Acad Sci U S A 1996;93:10939-44.
55. 55. DiScipio RG, Daffern PJ, Jagels MA, Broide DH, Sriramarao P. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in post-capillary venules and transendothelial migration in vitro and in vivo. J Immunol 1999;162:1127-36.
56. 56. Kitayama J, Mackay CR, Ponath PD, Springer TA. The C-C chemokine receptor CCR3 participates in stimulation of eosinophil arrest on inflammatory endothelium under flow. J Clin Invest 1998;101:2017-24.
57. 57. McNulty C, Symon FA, Wardlaw AJ. Characterisation of the integrin and activation steps in human eosinophil and neutrophil adhesion to endothelium in a model of chronic eosinophilic inflammation. Am J Resp Cell Mol Biol 1999;20:1251-9.
58. 58. Chin JE, Winterrowd GE, Hatfield CA, Brashler JR, Griffin RL, Vonderfecht SL, et al. Involvement of intercellular adhesion molecule-1 in the antigen-induced infiltration of eosinophils and lymphocytes into the airways in a murine model of pulmonary inflammation. Am J Respir Crit Care Med 1998;18:158-67.
59. 59. Gerwin N, Gonzalo JA, Lloyd C, Coyle AJ, Reiss Y, Banu N, et al. Prolonged eosinophil accumulation in allergic lung interstitiurn of ICAM-2 deficient mice results in extended hyperresponsiveness. Immunity 1999;10:9-19.
60. 60. Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, Schroder J-M. RANTES released by thrombin stimulated platelets is a potent histamine-releasing factor for human eosinophils. J Exp Med 1992;176:587-92.
61. 61. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-45.
62. 62. Ponath PD, Qin S, Ringler DJ, Clark-Lewis I, Wang J, Kassam N, et al. Cloning of the human eosinophil chemoattractant eotaxin: expression receptor binding and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996;97:604-12.
63. 63. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994;179:881-7.
64. 64. Patel VP, Kreider BL, Li Y, Li H, Leung K, Salcedo T, et al. Molecular and functional charactefisation of two novel human C-C chemokines as inhibitors of two distinct classes of myleoid progenitors. J Exp Med 1997;185:1163-72.
65. 65. Weber M, Uguccioni M, Ochensberger B, Baggioloin M, Clark-Lewis I, Dahinden CA. Monocyte chemotactic protein MCP-2 activates human basoplfil and eosinophil leukocytes similar to MCP-3. J Immunol 1995;154:4166-72.
66. 66. Dahinden CA, Geiser T, Brunner T, von Tscharner V, Caput D, Ferrara P, et al. Monocyte chemotactic protein 3 is a most effective basophil and eosinophil-activating chemokine. J Exp Med 1994;179:751-6.
67. 67. Uguccioni M, Loetscher P, Forssmann U, Dewald B, Li H, Lima SH, et al. Monoctye chemotactic protein 4 (MCP-4) a novel structural and functional analogue of MCP-3 and eotaxin. J Exp Med 1996;183:2379-84.
68. 68. Coulin F, Power CA, Alouani S, Peitsch MC, Schroeder JM, Moshizuki M, et al. Characterisation of macrophage inflammatory protein-5/human CC cytokine-2, a member of the macrophage-inflammatory protein family of chemokines. Eur J Biochem 1997;248:507-15.
69. 69. Ponath PD, Qin S, Post TW, Wang J, Wu L, Gerard NP, et al. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med 1996;183:2437-48.
70. 70. Uguccioni M, Mackay CR, Ochensgurger B, Loetscher P, Rhis S, LaRosa GJ, et al. High expression of the chemokine receptor CCR3 in human blood basophils: role in activation by eotaxin, MCP-4 and other chemokines. J Clin Invest 1997;100:1137-43.
71. 71. Sabroe I, Hartnell A, Jopling LA, Bel S, Ponath PD, Pease JE, et al. Differential regulation of eosinophil chemokine signalling via CCR3 and non-CCR3 pathways. J Immunol 1999;162:2946-55.
72. 72. Bochner BS, Bickel CA, Taylor ML, MacGlashen DW Jr, Gray PW, Raport CJ, et al. Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3 and CC chemokine receptor 4 independent manner. J Allergy Clin Immunol 1999;103:527-32.
73. 73. Erger RA, Casale TB. Interleukin-8 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium. Am J Physiol 1995;268:L117-22.
74. 74. Heath H, Qin S, Rao P, Wu L, LaRosa G, Kassam N, et al. Chemokine receptor usage by human eosinophils: the importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest 1997;99:178-84.
75. 75. Petering H, Gotze O, Kimmig D, Smolarski R, Kapp A, Elsner J. The biologic role of interleukin-8: functional analysis and expression of CXCR1 and CXCR2 on human eosinophils. Blood 1999;15:694-702.
76. 76. Sehmi R, Cromwell O, Wardlaw AJ, Moqbel R, Kay AB. Interleukin 8 is a chemoattractant for eosinophils purfied from subjects with a blood eosinophilia but not from normal healthy subjects. Clin Exp Allergy 1993;23:1027.
77. 77. Lamkhioued B, Renzi PM, Abi-Younes S, Garcia-Zepada EA, Allakhverdi Z, Ghaffar O, et al. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 1997;159:4593-601.
78. 78. Taha RA, Minshall EM, Miotto D, Shimbara A, Luster A, Hogg JC, et al. Eotaxin and monocyte chemotactic protein 4 mRNA expression in small airways of asthmatic and nonasthmatic individuals. J Allergy Clin Immunol 1999;103:476-83.
79. 79. Holgate ST, Bodey KS, Janezic A, Frew AJ, Kaplan AP, Teran LM. Release of RANTES, MIP-1 alpha and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am J Respir Crit Care Med 1997;156:1377-83.
80. 80. Humbert M, Ying S, Corrigan C, Menz G, Barkans J, Pfister R, et al. Bronchial mucosal expression of the genes encoding chernokines RANTES and MCP-3 in symptomatic atopic and non-atopic asthmatics: relationship to the eosinophil active cytokines interleukin (IL)-5, granulocyte macrophage colony stimulating factor and IL-3. Am J Respir Cell Mol Biol 1997;16:1-8.
81. 81. Gonzalo J-A, Jia G-Q, Aguirre V, Frined D, Coyle AJ, Jenkins NA, et al. Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity 1996;4:1-14.
82. 82. MacClean JA, Ownbey R, Luster AD. T cell-dependent regulation of eotaxin in antigen induced pulmonary eosinophilia. J Exp Med 1996;184:1461-9.
83. 83. Rothenberg ME, MacClean JA, Pearlman E, Luster AD, Leder P. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med 1997;185:785-90.
84. 84. Li L, Xia Y, Nguyen A, Feng L, Lo D. Th2-induced eotaxin expression and eosinophilia co-exist with Th 1 responses at the effector stage of lung inflammation. J Immunol 1998;161:3128-35.
85. 85. Gonzalo JA, Lloyd CM, Kremer L, Finger E, Martinez-A C, Siegelman MH, et al. Eosinophil recruitment to the lung in a murine model of allergic inflammation: the role of T cells chemokines and adhesion receptors. J Clin Invest 1996;98:2332-45.
86. 86. Gonzalo JA, Lloyd CM, Wen D, Albar JP, Wells TN, Proudfoot A, et al. The co-ordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresiveness. J Exp Med 1998;188:157-67.
87. 87. Stafford S, Li H, Forsythe PA, Ryan M, Bravo R, Alam R. Monocyte chemotactic protein-3 (MCP-3)/fibroblast induced cytokine (FIC) in eosinophilic inflammation of the airways and the inhibitory effects of an anti-MCP-3/FIC antibody. J Immunol 1997;158:4953-60.
88. 88. Yang Y, Loy J, Ryseck RP, Carrasco D, Bravo R. Antigen-induced eosinophilic lung inflammation develops in mice deficient in chemokine eotaxin. Blood 1998;92:3912-23.
89. 89. Li L, Nguyen A, Lai YH, Fenng L, Mosmann TR, Lo D. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 1999;162:2477-87.
90. 90. Doucet C, Brouty-Boye D, Pottin-Clenceau C, Canoninca GW, Jasmin C, Azzarone B. Interleukin (IL)4 and IL-13 act on human lung fibroblasts: implication in asthma. J Clin Invest 1998;101:2129-39.
91. 91. Teran LM, Mochizuki M, Barrels J, Valencia EL, Nakajima T, Hirai K, et al. Th1 and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am J Respir Cell Mol Biol 199;20:777-86.
92. 92. Simon H-U, Alam R. Regulation of eosinophil apoptosis: transduction of survival and death signals. Int Arch Allergy Clin Immunol 1999;118:7-14.
93. 93. Hans-Uwe S, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;158:3902-8.
94. 94. Tsuyuki S, Betrand C, Erard F, Tfifilieff A, Tsuyuki J, Wesp M, et al. Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways. J Clin Invest 1995;96:2924-31.
95. 95. Druilhe A, Wallaert B, Tsicopoulos A, Lapa e Silva JR, Tillie-Leblond I, Tonnel AB, et al. Apoptosis, proliferation and expression of Bcl-2,Fas and Fas ligand in bronchial biopsies from asthmatics. Am J Respir Cell Mol Biol 1998;19:747-57.
96. 96. Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996;156:4422-8.
97. 97. Horn BR, Robin ED, Theodore J, Van Kessel A. Total eosinophil counts in the management of bronchial asthma. N Engl J Med 1975;292:1152-5.
98. 98. Patel KD. Mechanisms of selective leukocyte recruitment from whole blood on cytokine activated endothelial cells under flow conditions. J Immunol 1999;162:6209-16.
99. 99. Shute JK, Vrugt D, Lindley IJ, Holgate ST, Bron A, Aalbers R, et al. Free and complexed intefieukin-8 in blood and bronchial mucosa in asthma. Am J Respir Crit Care Med 1997;155:1877-83.
100. 100. Wills-Karp M. Immunologic basis of antigen-induced airvay hyperresponsiveness. Annu Rev Immunol 1999;17:255-81.
101. 101. Strauss EC, Larson KA, Brenneisse I, Foster CS, Larsen GR, Lee NA, et al. Solubale P-selectin glycoprotein ligand i inhibits ocular inflammation in a murine model of allergy. Invest Opthalmol Vis Sci 1999;40:1336-42.
102. 102. Powell WS, Gravel S, Halwani F. 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of L-selectin shedding, surface expression of CD 11 b, actin polymerization and calcium mobilization in human eosinophils. Am J Respir Cell Mol Biol 1999;20:163-70.
103. 103. Akimoto T, Numata F, Tumuara M, Takala T, Higashida N, Takashi T, et al. Abrogation of bronchial eosinophilic inflammation and aim, ay hyperreactivity in signal transducers and activators of transcription (STAT) 6-deficient mice. J Exp Med 1998;187:1537-42.